revealed Dr Muhammad Awad Taj El-Din, adviser to the president on health and prevention affairs, in an exclusive statement to “The Seventh Day”, which Respiratory syncytial virus It is a virus within a group of respiratory viruses that has been around for a long time and is a very large group of about 20-30 species.
And he continued: that when the child complains, the symptoms are high fever, shortness of breath, cough, inflammation and pain in the throat, and when presented to the doctor, the patient is diagnosed with a respiratory virus because all viruses give symptoms similar to the flu, Corona virus also currently causes flu-like symptoms, however, these days, the presence of Corona and other viruses has made people interested in respiratory syncytial virus, but it is an old and widespread virus, not an epidemic, and we treat this type of virus easily, just like the flu, so there is no need to worry and it does not cause any serious complications.
On the other hand, Pfizer had announced its experimental respiratory syncytial virus vaccine (RSV) It was shown to be effective in preventing serious infections in infants after being given in a late-stage study to pregnant women in their second trimester of pregnancy, according to the Pfizer website and the Reuters website..
Pfizer’s injection, if approved, could be the first maternal vaccine available to reduce the burden of disease in young children, and the company plans to submit it for approval by the end of 2022..
“Vaccination of mothers benefits from being able to protect a baby from day one, which is important as these babies hit peak hospital admissions for respiratory syncytial virus,” said Kenna Swanson, vice president of viral vaccines at Pfizer. rsv He’s about one or two months old.
Two companies are competing, PfizerPfizer and GlaxoSmithKline GSK extension Develop a vaccine against respiratory syncytial virus rsvA leading cause of pneumonia in young children and the elderly, the vaccine is expected to generate billions of dollars in sales upon approval.
Estimated data, Respiratory syncytial virus rsv58,000 children under the age of five are admitted to US hospitals each year.
The Pfizer vaccine showed 81.8% efficacy in preventing a severe form of lower respiratory tract disease in infants in the first 90 days. Signs of severe disease in the study included extremely low oxygen levels, being put on a ventilator, being in an intensive care unit, or losing consciousness due to respiratory syncytial virus.
The missed endpoint was disease reduction in infants requiring care from a healthcare professional, according to Reuters, explaining that respiratory syncytial virus infection is on the rise among young children in the United States and there are currently no vaccines. against the virus. rsv In August, Pfizer announced its respiratory syncytial virus (RSV) vaccine. rsv It was effective among older adults in a late-stage study.
While she said Glaxo said GSK extension In October, the vaccine was 82.6% effective in a late-stage study involving older adults.
Pfizer Inc. president Angela Lukin said at an October conference that potential approval of Pfizer’s vaccine for pregnant women and adults would make it “the only company with an indication for both maternal and elderly people”.“.
According to the US Centers for Disease Control and Prevention website“CENTER FOR DISEASE CONTROL AND PREVENTION”it is a respiratory syncytial virus rsv is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover within a week or two, but RSV can be serious, especially in infants and the elderly, as it is the most common cause of bronchiolitis (inflammation of the small airways in the lung) and pneumonia (infection of the lungs) in children under 1 year of age in the United States.
